Literature DB >> 22889002

The essential role of anti-thyroid antibodies in chronic idiopathic urticaria.

Kong-Sang Wan1, Chyi-Sen Wu.   

Abstract

BACKGROUND: An autoimmune etiology has been suggested in up to one-third of cases of chronic idiopathic urticaria (CIU), in which it has been proposed that a subset of cases are associated with thyroid autoimmunity. The objective of our present study was to verify the prevalence of thyroid antibodies in the patients with CIU.
METHODS: Sixty patients aged 12-51 years, who met criteria for CIU, and 40 aged-matched healthy controls (18 males and 22 females) were participated in this study. Serum anti-thyroid antibodies (ATAs), thyroid hormones, total immunoglobulin E (IgE), and food allergen-specific IgE antibodies were measured. The CIU group was treated with anti-H1 and anti-H2 histamines for 3 weeks.
RESULTS: The total ATA positive rate was 27.3% (33% males and 25% females) in the CIU group. The prevalence of anti-thyroglobulin antibodies, anti-TSH-receptor antibodies, and anti-thyroid peroxidase antibodies were 16.6%, 83.3%, and 8.3%, respectively. The thyroid hormones, T3, and T4, and the TSH were within the normal limits. The radioallergosorbent test was negative for food allergens, and only 18% of the patients had a total IgE concentration >200 IU/mL.
CONCLUSION: ATAs were found in 27% of the patients with CIU, but these antibodies did not dysregulate thyroid hormone secretion nor did they mediate any clinical manifestations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22889002     DOI: 10.3109/07435800.2012.714432

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  7 in total

Review 1.  The prevalence of thyroid autoimmunity in patients with urticaria: a systematic review and meta-analysis.

Authors:  Xi-Feng Pan; Jian-Qiu Gu; Zhong-Yan Shan
Journal:  Endocrine       Date:  2014-07-27       Impact factor: 3.633

2.  Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria.

Authors:  Priyal Amin; Linda Levin; Sarah J Holmes; Jillian Picard; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol Pract       Date:  2015-02-11

Review 3.  Presence of positive skin prick tests to inhalant allergens and markers of T2 inflammation in subjects with chronic spontaneous urticaria (CSU): a systematic literature review.

Authors:  Melanie Mitsui Wong; Paul Kevin Keith
Journal:  Allergy Asthma Clin Immunol       Date:  2020-08-04       Impact factor: 3.406

4.  FACTORS CONTRIBUTING TO CHRONIC URTICARIA/ANGIOEDEMA AND NUMMULAR ECZEMA RESOLUTION - WHICH FINDINGS ARE CRUCIAL?

Authors:  Liborija Lugović-Mihić; Iva Bukvić; Vedrana Bulat; Iva Japundžić
Journal:  Acta Clin Croat       Date:  2019-12       Impact factor: 0.780

5.  Chronic urticaria and thyroid autoimmunity: a meta-analysis of case-control studies.

Authors:  D Tienforti; F Di Giulio; L Spagnolo; C Castellini; M Totaro; M Muselli; S Francavilla; M G Baroni; A Barbonetti
Journal:  J Endocrinol Invest       Date:  2022-02-18       Impact factor: 5.467

Review 6.  Chronic urticaria: Indian context-challenges and treatment options.

Authors:  Sujoy Khan; Anirban Maitra; Pravin Hissaria; Sitesh Roy; Mahesh Padukudru Anand; Nalin Nag; Harpal Singh
Journal:  Dermatol Res Pract       Date:  2013-09-24

Review 7.  Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients.

Authors:  Kiran Godse; Murlidhar Rajagopalan; Mukesh Girdhar; Sanjiv Kandhari; Bela Shah; Prashant N Chhajed; Sushil Tahiliani; D S Krupa Shankar; Vijay Somani; Vijay Zawar
Journal:  Indian Dermatol Online J       Date:  2016 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.